Aligos Therapeutics Inc (ALGS) stock news · rev $2.2M
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
This ALGS news page leads with what Aligos Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for ALGS yet. We will not pad this page with generic market recap.
Latest reported ALGS revenue for 2025-12-31 was $2.2M. Net income was -$24.2M. Revenue was down 39.5% from 2024-12-31 to 2025-12-31. ALGS currently screens at market cap $44.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the ALGS stock page; for the tape open the quote page.
ALGS stock news FAQ
What are ALGS's latest revenue and net income?
Latest cached Aligos Therapeutics Inc (ALGS) revenue for Dec 31, 2025 was $2.2M. Net income was -$24.2M. Statements: https://lician.com/financials/algs
How did ALGS revenue change from the prior cached period?
Cached Aligos Therapeutics Inc (ALGS) revenue was down 39.5% from $3.6M (Dec 31, 2024) to $2.2M (Dec 31, 2025). Statements: https://lician.com/financials/algs
What is ALGS's market cap?
Aligos Therapeutics Inc (ALGS) market cap is $44.1M on the latest cached fundamentals snapshot.
What kind of company is ALGS?
Aligos Therapeutics Inc (ALGS) is a biotechnology company listed on US.
Where is ALGS stock news listed?
Cached stock news for Aligos Therapeutics Inc (ALGS) is listed at https://lician.com/news/algs. Filings: https://lician.com/sec/algs
Not investment advice.